Member Login
  1. Stocks
    2. /
  2. Allergy Therapeutics plc (LSE: AGY)
    3. /

LSE:AGY (Allergy Therapeutics plc)

About AGY

Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Allergy Therapeutics plc (LSE: AGY) Latest News

    British Pennies on a Pound Note
    Investing Articles

    3 penny stocks to look out for in September

    | Alan Oscroft

    Do penny stocks offer exceptional growth potential? They might, if they don't go bust first. Here are three reporting in…

    Read more »

    Investing Articles

    Here’s what UK shares Wood Group and Allergy Therapeutics reported today!

    | Royston Wild

    The Wood Group share price has plummeted following the release of fresh financials. Here are the key things coming out…

    Read more »

    Investing Articles

    Should you be investing money in pharma stocks?

    | Toby Aston

    The healthcare and pharmaceutical industry has been growing steadily for years. The UK in particular is home to pharma giants…

    Read more »

    Investing Articles

    Allergy Therapeutics’ share price has risen 67% since March’s stock market crash

    | Kirsteen Mackay

    Allergy Therapeutics’ share price has been climbing in April, can this growth be sustained and is this a pharmaceutical stock…

    Read more »

    Investing Articles

    2 overlooked growth shares I’d consider buying for the next 10 years

    | Alan Oscroft

    Here's one growth share that I think has been plodding along nicely, and another that could be coming back from…

    Read more »

    Investing Articles

    Why I’d sell Purplebricks Group plc to buy this growth stock

    | Alan Oscroft

    Purplebricks Group plc (LON: PURP) could have flown too far too soon, but here's a growth candidate that's yet to…

    Read more »

    Investing Articles

    Do today’s results make this company a better buy than Shire plc?

    | Peter Stephens

    Should you avoid Shire plc (LON: SHP) in favour of this healthcare peer?

    Read more »

    Investing Articles

    Why GlaxoSmithKline plc, Allergy Therapeutics plc and Consort Medical plc are a dying breed

    | Peter Stephens

    These 3 stocks are examples of an increasingly rare segment of the stock market: GlaxoSmithKline plc (LON: GSK), Allergy Therapeutics…

    Read more »